Skip to main content

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Perspective Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
43
+4 vs. Q1 2022
Shares held
16.8M
+844.1K (+5.3%) vs. Q1 2022
Total value
$5.19M
−$597.2K (−10.3%) vs. Q1 2022
New holders
8
7 more added
Sold out
4
9 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CATX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 43 institutions
Q1 2021: 57 institutionsQ2 2021: 48 institutionsQ3 2021: 43 institutionsQ4 2021: 45 institutionsQ1 2022: 39 institutionsQ2 2022: 43 institutionsQ3 2022: 35 institutionsQ4 2022: 48 institutionsQ1 2023: 42 institutionsQ2 2023: 50 institutionsQ3 2023: 49 institutionsQ4 2023: 52 institutionsQ1 2024: 104 institutionsQ2 2024: 105 institutionsQ3 2024: 127 institutionsQ4 2024: 135 institutionsQ1 2025: 112 institutionsQ2 2025: 98 institutionsQ3 2025: 105 institutionsQ4 2025: 117 institutionsQ1 2026: 138 institutionsQ2 2026: 131 institutions
Value heldQ2 2022: $5.19M
Q1 2021: $20.2MQ2 2021: $13.9MQ3 2021: $9.99MQ4 2021: $6.78MQ1 2022: $5.79MQ2 2022: $5.19MQ3 2022: $3.70MQ4 2022: $4.26MQ1 2023: $17.8MQ2 2023: $22.0MQ3 2023: $9.99MQ4 2023: $14.7MQ1 2024: $294.6MQ2 2024: $384.9MQ3 2024: $654.9MQ4 2024: $150.7MQ1 2025: $96.4MQ2 2025: $146.3MQ3 2025: $150.1MQ4 2025: $105.0MQ1 2026: $333.1MQ2 2026: $297.6M
Institutions holding CATX and their total value by quarter
QuarterHoldersValue
Q2 2026131$297.6M
Q1 2026138$333.1M
Q4 2025117$105.0M
Q3 2025105$150.1M
Q2 202598$146.3M
Q1 2025112$96.4M
Q4 2024135$150.7M
Q3 2024127$654.9M
Q2 2024105$384.9M
Q1 2024104$294.6M
Q4 202352$14.7M
Q3 202349$9.99M
Q2 202350$22.0M
Q1 202342$17.8M
Q4 202248$4.26M
Q3 202235$3.70M
Q2 202243$5.19M
Q1 202239$5.79M
Q4 202145$6.78M
Q3 202143$9.99M
Q2 202148$13.9M
Q1 202157$20.2M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Perspective Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding CATX in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc6,047,815$1.87M0.00%00.0%Unchanged
Perkins Capital Management Inc2,914,500$901.0K0.93%+116,000+4.1%Added
BlackRock Inc.2,445,353$756.0K0.00%+6,135+0.3%Added
Geode Capital Management, LLC1,131,105$349.0K0.00%+12,035+1.1%Added
Taylor & Morgan Wealth Management, LLC775,354$240.0K0.23%+225,354+41.0%Added
Bard Associates Inc669,200$207.0K0.09%00.0%Unchanged
State Street Corp553,619$171.0K0.00%00.0%Unchanged
Venator Capital Management Ltd.550,000$170.0K0.29%+550,000New
Renaissance Technologies LLC377,092$117.0K0.00%−40,223−9.6%Reduced
Northern Trust Corp244,360$76.0K0.00%−17,189−6.6%Reduced
Bridgeway Capital Management, LLC184,000$57.0K0.00%00.0%Unchanged
Creative Planning129,500$40.0K0.00%00.0%Unchanged
Morgan Stanley84,059$26.0K0.00%−6,571−7.3%Reduced
Bank of New York Mellon Corp77,229$24.0K0.00%00.0%Unchanged
Two Sigma Advisers, LP54,400$17.0K0.00%−11,400−17.3%Reduced
Crestwood Advisors Group LLC54,824$17.0K0.00%00.0%Unchanged
Citadel Advisors LLC41,020$13.0K0.00%−85,920−67.7%Reduced
Cerity Partners LLC40,000$12.0K0.00%00.0%Unchanged
Millennium Management LLC37,266$12.0K0.00%−860−2.3%Reduced
Susquehanna International Group, LLP35,327$11.0K0.00%+17,139+94.2%Added
WCG Wealth Advisors LLC34,022$11.0K0.00%+34,022New
Two Sigma Securities, LLC31,729$10.0K0.00%+31,729New
Bremer Bank National Association29,411$9.00K0.00%00.0%Unchanged
Commonwealth Equity Services, LLC26,284$8.00K0.00%00.0%Unchanged
Royal Bank of Canada25,000$8.00K0.00%−134−0.5%Reduced
Virtu Financial LLC24,471$8.00K0.00%+24,471New
Ameriprise Financial Inc18,000$6.00K0.00%00.0%Unchanged
TMD Wealth Management, LLC20,000$6.00K0.00%00.0%Unchanged
Victory Capital Management Inc19,954$6.00K0.00%−135−0.7%Reduced
Jane Street Group, LLC20,774$6.00K0.00%+8,743+72.7%Added
Raymond James Financial Services Advisors, Inc.17,500$5.00K0.00%00.0%Unchanged
UBS Group AG17,458$5.00K0.00%+16,778+2,467.4%Added
Auxier Asset Management14,218$4.00K0.00%00.0%Unchanged
Great Valley Advisor Group, Inc.12,000$4.00K0.00%+12,000New
Capital Advisors Inc10,000$3.00K0.00%00.0%Unchanged
Wealth Effects LLC10,000$3.00K0.00%00.0%Unchanged
Wells Fargo & Company6,231$2.00K0.00%−23−0.4%Reduced
JNBA Financial Advisors5,000$2.00K0.00%00.0%Unchanged
TD Waterhouse Canada Inc.2,000$5840.00%00.0%Unchanged
Arcadia Investment Advisors LLC222$690.00%00.0%Unchanged
Bank of America Corp1,000$00.00%+1,000New
Chilton Capital Management LLC500$00.00%+500New
Northwestern Mutual Wealth Management Co82$00.00%+82New
Bullseye Investment Management, LLC0$00.00%−25,000−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−13,795−100.0%Sold out
Douglass Winthrop Advisors, LLC0$00.00%−10,000−100.0%Sold out
FNY Investment Advisers, LLC0$00.00%−600−100.0%Sold out